AP
AMGN icon

Atwood & Palmer’s Amgen AMGN Stock Holding History

Atwood & Palmer’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
5,540
-107
-2% -$36.6K 0.11% 71
2026
Q1 		$1.99M Sell
5,647
-577
-9% -$206K 0.11% 71
2025
Q4 		$2.04M Hold
6,224
– – 0.12% 67
2025
Q3 		$1.76M Hold
6,224
– – 0.1% 72
2025
Q2 		$1.74M Buy
6,224
+27
+0.4% +$7.65K 0.11% 72
2025
Q1 		$1.93M Sell
6,197
-40
-0.6% -$11.8K 0.13% 70
2024
Q4 		$1.63M Buy
6,237
+31
+0.5% +$9.2K 0.11% 71
2024
Q3 		$2M Sell
6,206
-4
-0.1% -$1.31K 0.14% 65
2024
Q2 		$1.94M Buy
6,210
+47
+0.8% +$13.8K 0.15% 65
2024
Q1 		$1.75M Hold
6,163
– – 0.13% 65
2023
Q4 		$1.78M Sell
6,163
-35
-0.6% -$9.54K 0.14% 64
2023
Q3 		$1.67M Hold
6,198
– – 0.15% 63
2023
Q2 		$1.38M Sell
6,198
-84,419
-93% -$19.6M 0.12% 75
2023
Q1 		$21.9M Buy
90,617
+475
+0.5% +$117K 2.06% 19
2022
Q4 		$23.7M Buy
90,142
+1,310
+1% +$351K 2.14% 14
2022
Q3 		$20M Buy
88,832
+990
+1% +$240K 1.98% 17
2022
Q2 		$21.4M Buy
87,842
+23,161
+36% +$5.68M 2.08% 15
2022
Q1 		$15.6M Buy
64,681
+2,325
+4% +$534K 1.35% 33
2021
Q4 		$14M Buy
62,356
+3,456
+6% +$729K 1.17% 34
2021
Q3 		$12.5M Buy
58,900
+1,056
+2% +$243K 1.12% 35
2021
Q2 		$14.1M Buy
57,844
+3,435
+6% +$845K 1.27% 33
2021
Q1 		$13.5M Buy
54,409
+904
+2% +$216K 1.3% 31
2020
Q4 		$12.3M Buy
53,505
+3,316
+7% +$765K 1.32% 30
2020
Q3 		$12.8M Buy
50,189
+1,265
+3% +$313K 1.61% 26
2020
Q2 		$11.5M Buy
48,924
+365
+0.8% +$83.3K 1.56% 27
2020
Q1 		$9.84M Buy
48,559
+38,706
+393% +$8.45M 1.55% 25
2019
Q4 		$2.38M Hold
9,853
– – 0.31% 51
2019
Q3 		$1.91M Hold
9,853
– – 0.26% 54
2019
Q2 		$1.82M Sell
9,853
-1,450
-13% -$260K 0.25% 57
2019
Q1 		$2.15M Sell
11,303
-285
-2% -$54.4K 0.3% 48
2018
Q4 		$2.26M Sell
11,588
-365
-3% -$71.2K 0.36% 45
2018
Q3 		$2.48M Sell
11,953
-203
-2% -$40K 0.32% 46
2018
Q2 		$2.24M Sell
12,156
-225
-2% -$39.8K 0.31% 48
2018
Q1 		$2.11M Hold
12,381
– – 0.3% 49
2017
Q4 		$2.15M Buy
12,381
+1,200
+11% +$212K 0.3% 47
2017
Q3 		$2.08M Hold
11,181
– – 0.3% 49
2017
Q2 		$1.93M Hold
11,181
– – 0.3% 49
2017
Q1 		$1.83M Sell
11,181
-100
-0.9% -$16.6K 0.29% 49
2016
Q4 		$1.65M Sell
11,281
-2,500
-18% -$376K 0.3% 47
2016
Q3 		$2.3M Hold
13,781
– – 0.42% 43
2016
Q2 		$2.1M Sell
13,781
-200
-1% -$31.1K 0.38% 47
2016
Q1 		$2.1M Sell
13,981
-4,726
-25% -$702K 0.37% 48
2015
Q4 		$3.04M Hold
18,707
– – 0.58% 46
2015
Q3 		$2.59M Hold
18,707
– – 0.51% 49
2015
Q2 		$2.87M Sell
18,707
-134
-0.7% -$21.5K 0.52% 49
2015
Q1 		$3.01M Sell
18,841
-1,075
-5% -$169K 0.54% 49
2014
Q4 		$3.17M Sell
19,916
-14,888
-43% -$2.32M 0.59% 43
2014
Q3 		$4.64M Buy
34,804
+1,395
+4% +$182K 0.88% 37
2014
Q2 		$3.96M Sell
33,409
-792
-2% -$91.7K 1.06% 35
2014
Q1 		$4.22M Buy
34,201
+366
+1% +$44.4K 0.99% 31
2013
Q4 		$3.86M Hold
33,835
– – 0.95% 30
2013
Q3 		$3.79M Hold
33,835
– – 1.05% 29
2013
Q2 		$3.34M Buy
+33,835
New +$3.51M 0.9% 31

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Atwood & Palmer's AMGN Position: Q2 2026 in Review

Atwood & Palmer reduced its Amgen (AMGN) stake by 1.9% in Q2 2026, selling an estimated $36.6K and leaving 5,540 shares worth $2.01M. The position accounts for 0.11% of the portfolio, ranked #71.

Atwood & Palmer first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.7M in Q4 2022. 836 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Atwood & Palmer held 5,540 shares of Amgen worth $2.01M as of Q2 2026.
  • Atwood & Palmer sold 107 Amgen shares in Q2 2026, an estimated $36.6K.
  • Amgen made up 0.11% of Atwood & Palmer's portfolio in Q2 2026, its #71 holding.
  • Atwood & Palmer first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Atwood & Palmer's Amgen position peaked at $23.7M in Q4 2022.
  • 836 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.